Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer

Ovarian cancer is the second most common gynecologic cancer in the US and ranks among the top 10 causes of female cancer-related deaths. Platinum-resistant disease carries a particularly poor prognosis and leaves patients with limited remaining therapeutic options. Patients with platinum-resistant d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinney, Rachel E, Nair, Suresh, Kim, Christine H, Thomas, M Bijoy, DelaTorre, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243776/
https://www.ncbi.nlm.nih.gov/pubmed/37027520
http://dx.doi.org/10.1093/oncolo/oyad079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243776/
https://www.ncbi.nlm.nih.gov/pubmed/37027520
http://dx.doi.org/10.1093/oncolo/oyad079

Ejemplares similares